journal article·2024-12-18

NIR-II Light-Driven Multifunctional Nanozymes PS@CS for Efficient Therapy against Melanoma and Post-tumor Surgery Infection

Rui Gong, Decai Yang, Cuijuan Zhang, Ghulam Abbas, Beiping Miao, Yueyue Liang, Jianing Xu, Xueyang Fang, Hui Ding

Nano Letters· Volume 24· Issue 50
Publisher page

Abstract

Melanoma, the most prevalent form of skin cancer, is primarily treated with surgical intervention. However, complete tumor cell removal is challenging, and surgical wounds are prone to infection, complicating treatment and increasing costs. The successful treatment of melanoma generally requires multifunctional agents that are coordinated in tumor therapy and wound healing. In this study, we developed platinum (Pt)- and selenium (Se)-based nanozymes, Pt-Se@Chitosan (PS@CS), which exhibit synergistic antitumor and bactericidal efficacy attributed to their multienzyme activity and strong photothermal conversion efficiency. Furthermore, we engineered PS@CS hydrogels capable of inhibiting tumor regrowth postsurgery and accelerating healing of infected wounds. The PS@CS and PS@CS hydrogels presented herein incorporate characteristics including catalytic therapy, photothermal therapy, antibacterial properties, and skin damage healing, providing an innovative and comprehensive therapeutic approach for melanoma treatment.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced Nanomaterials in Catalysis · Nanoplatforms for cancer theranostics · Nanocluster Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Medical Innovation Technology Transformation Center, Shenzhen Key Laboratory of Nanozymes and Translational Cancer Research, Department of Otolaryngology, Shenzhen Institute of Translational Medicine, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People’s Hospital, Shenzhen 518039, China

Faculty of Synthetic Biology, Shenzhen University of Advanced Technology, Shenzhen 518107, China

Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou 511436, China

Department of Cardiovascular Surgery, First Center of 301 Chinese PLA General Hospital, Beijing 100853, China

Institute of Synthetic Biology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China

Department of Otolaryngology, Shenzhen Second People’s Hospital, The First Affiliated Hospital of Shenzhen University, Shenzhen 518039, China

Department of Otorhinolaryngology, Qilu Hospital of Shandong University, NHC Key Laboratory of Otorhinolaryngology (Shandong University), Jinan, Shandong 250012, China

MOE Key Laboratory of Laser Life Science & Institute of Laser Life Science, Guangdong Provincial Key Laboratory of Laser Life Science, College of Biophotonics, School of Optoelectronic Science and Engineering, South China Normal University, Guangzhou 510631, China

Funding

Basic and Applied Basic Research Foundation of Guangdong Province · Shenzhen Science and Technology Innovation Commission · Development and Reform Commission of Shenzhen Municipality · National Natural Science Foundation of China · Natural Science Foundation of Guangdong Province · Shenzhen Portion of Shenzhen-Hong Kong Science and Technology Innovation Cooperation Zone

References (26)

Show source-provided references
1. 10.1038/s41568-023-00565-710.1038/s41568-023-00565-7 ↗
2. 10.3322/canjclin.50.4.21510.3322/canjclin.50.4.215 ↗
3. 10.1016/j.jaad.2022.01.05310.1016/j.jaad.2022.01.053 ↗
4. 10.1002/adfm.20180688310.1002/adfm.201806883 ↗
5. 10.1016/j.addr.2018.03.01210.1016/j.addr.2018.03.012 ↗
6. 10.1126/scitranslmed.300933710.1126/scitranslmed.3009337 ↗
7. 10.3322/CA.2007.000310.3322/CA.2007.0003 ↗
8. 10.1002/advs.20230411010.1002/advs.202304110 ↗
9. 10.1038/nnano.2007.26010.1038/nnano.2007.260 ↗
10. 10.1002/adma.20230524910.1002/adma.202305249 ↗
11. 10.1002/adma.20221104110.1002/adma.202211041 ↗
12. 10.1021/acs.chemrev.6b0052510.1021/acs.chemrev.6b00525 ↗
13. 10.1080/15384047.2016.125098810.1080/15384047.2016.1250988 ↗
14. 10.1158/0008-5472.948.65.310.1158/0008-5472.948.65.3 ↗
15. 10.1016/j.ccr.2023.21504910.1016/j.ccr.2023.215049 ↗
16. 10.1021/acs.accounts.9b0013610.1021/acs.accounts.9b00136 ↗
17. 10.1039/C6CS00271D10.1039/C6CS00271D ↗
18. 10.1021/acs.accounts.8b0021410.1021/acs.accounts.8b00214 ↗
19. 10.1039/c3cs35486e10.1039/c3cs35486e ↗
20. 10.1002/adma.20231340610.1002/adma.202313406 ↗
21. 10.1038/s41596-024-01034-710.1038/s41596-024-01034-7 ↗
22. 10.1002/anie.20210192410.1002/anie.202101924 ↗
23. 10.1021/acs.chemmater.9b0195810.1021/acs.chemmater.9b01958 ↗
24. 10.1002/adfm.20210132010.1002/adfm.202101320 ↗
25. 10.1016/j.bioactmat.2021.04.02410.1016/j.bioactmat.2021.04.024 ↗
26. 10.1002/adma.20221045510.1002/adma.202210455 ↗